Tracking the daily impact of a Parkinson's medication pump

NCT ID NCT07219927

Summary

This study is observing how 120 people with Parkinson's disease use a continuous medication pump (ONAPGO™) in their daily lives. The pump delivers a drug called apomorphine under the skin to help control movement symptoms. Researchers will track how long it takes to find the right dose, how patients and caregivers feel, and what side effects occur during real-world use.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-••••

Locations

  • Parkinson's Disease & Movement Disorders Center of Boca Raton

    RECRUITING

    Boca Raton, Florida, 33486, United States

    Contact

    Contact

  • Parkinson's Disease and Movement Disorders Center - Long Island

    RECRUITING

    Commack, New York, 11725, United States

    Contact

    Contact

  • Parkinson's Disease and Movement Disorders Center - Orange County (North)

    RECRUITING

    Irvine, California, 92618, United States

    Contact

    Contact

  • Parkinson's Disease and Movement Disorders Center - Orange County (South)

    RECRUITING

    Aliso Viejo, California, 92656, United States

    Contact

    Contact

  • Parkinson's Research Centers of America - Palo Alto

    RECRUITING

    Palo Alto, California, 94301, United States

    Contact

    Contact

Conditions

Explore the condition pages connected to this study.